SCHEMBL2433795

SCHEMBL2433795

CCOC(=O)C1(COc2ccc(-c3ccc(F)cc3)cc2)CCN(C(=O)c2ccc(F)cc2)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 3/20 0.56
PTGER4 P35408 1/20 0.56
PTGDR Q13258 1/20 0.56
DRD1 P21728 1/20 0.54
HRH4 Q9H3N8 1/20 0.54
NQO2 P16083 1/20 0.51
PDE3B Q13370 1/20 0.51
PDE3A Q14432 1/20 0.51
LTB4R Q15722 1/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.51
GAA P10253 1/20 0.49
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 1/20 0.47
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
P4HB P07237 1/20 0.47
HRH2 P25021 1/20 0.45
HRH1 P35367 1/20 0.45
HPGD P15428 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2434921 0.96 PTGER2 (0.62) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2440236 0.96 PTGER2 (0.53) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2433396 0.94 PTGER2 (0.67) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2438543 0.91 PTGER2 (0.48) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2432590 0.89 PTGER2 (0.43) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2441662 0.89 PTGER2 (0.46) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2436247 0.88 PTGER2 (0.52) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2435356 0.87 KMT2A (0.45) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL12854016 0.87 HTT (0.48) PTGER2PTGER4PTGDRDRD1HRH4
SCHEMBL2434756 0.87 PTGER2 (0.44) PTGER2PTGER4PTGDRDRD1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278343-B2 Pyrrolidines PFIZER INC. (US) 2012-10-02 US disclosed
US-8278343-B2 Pyrrolidines PFIZER INC. (US) 2012-10-02 US disclosed
US-8278343-B2 Pyrrolidines PFIZER INC. (US) 2012-10-02 US disclosed
EP-2364296-A1 PYRROLIDINES Pfizer Limited (GB) 2011-09-14 EP disclosed
WO-2010052625-A1 PYRROLIDINES PFIZER LIMITED (GB) 2010-05-14 WO disclosed
WO-2010052625-A1 PYRROLIDINES PFIZER LIMITED (GB) 2010-05-14 WO disclosed
US-20100120793-A1 Pyrrolidines PFIZER ANIMAL HEALTH UK 1 LIMITED (GB) 2010-05-13 US disclosed
US-20100120793-A1 Pyrrolidines PFIZER ANIMAL HEALTH UK 1 LIMITED (GB) 2010-05-13 US disclosed
US-20100120793-A1 Pyrrolidines PFIZER ANIMAL HEALTH UK 1 LIMITED (GB) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120793-A1 Pyrrolidines PTGER2, PTGDR2, PTGES2 PTGER2 1/4885PTGER4 11/4885PTGDR 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.